Case Report: Adequate T and B Cell Responses in a SARS-CoV-2 Infected Patient After Immune Checkpoint Inhibition

After the COVID-19 outbreak, non-evidence based guidelines were published to advise clinicians on the adjustment of oncological treatment during this pandemic. As immune checkpoint inhibitors directly affect the immune system, concerns have arisen about the safety of immunotherapy during this pandem...

Descripción completa

Detalles Bibliográficos
Autores principales: de Joode, K., Oostvogels, A. A. M., GeurtsvanKessel, C. H., de Vries, R. D., Mathijssen, R. H. J., Debets, R., van der Veldt, A. A. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889602/
https://www.ncbi.nlm.nih.gov/pubmed/33613575
http://dx.doi.org/10.3389/fimmu.2021.627186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889602/
https://www.ncbi.nlm.nih.gov/pubmed/33613575
http://dx.doi.org/10.3389/fimmu.2021.627186

Ejemplares similares